Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2001 Spring;7(1):48-120.
doi: 10.1111/j.1527-3458.2001.tb00190.x.

Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review

L Delgado-Herrera  1 , R D Ostroff, S A Rogers
Affiliations
Review

Sevoflurance: approaching the ideal inhalational anesthetic. a pharmacologic, pharmacoeconomic, and clinical review

L Delgado-Herrera et al. CNS Drug Rev. 2001 Spring.

Abstract

Sevoflurane is a safe and versatile inhalational anesthetic compared with currently available agents. Sevoflurane is useful in adults and children for both induction and maintenance of anesthesia in inpatient and outpatient surgery. Of all currently used anesthetics, the physical, pharmacodynamic, and pharmacokinetic properties of sevoflurane come closest to that of the ideal anesthetic (200). These characteristics include inherent stability, low flammability, non-pungent odor, lack of irritation to airway passages, low blood:gas solubility allowing rapid induction of and emergence from anesthesia, minimal cardiovascular and respiratory side effects, minimal end-organ effects, minimal effect on cerebral blood flow, low reactivity with other drugs, and a vapor pressure and boiling point that enables delivery using standard vaporization techniques. As a result, sevoflurane has become one of the most widely used agents in its class.

PubMed Disclaimer

References

    1. Ahmed AA, Kumagai M, Otake T, et al. Sevoflurane exposure time and the neuromuscular blocking effect of vecuronium. Can J Anaesth 1999;46:429–432. - PubMed
    1. Alexander R, Lindsay D. No time to change. Can J Anaesth 1999;46:94. - PubMed
    1. Artru AA, Lam AM, Johnson JO, et al. Intracranial pressure, middle cerebral artery flow velocity, and plasma inorganic fluoride concentrations in neurosurgical patients receiving sevoflurane or isoflurane. Anesth Analg 1997;85:587–592. - PubMed
    1. Artru AA. Renal effects of sevoflurane during conditions of possible increased risk. J Clin Anesth 1998;10:539–545. - PubMed
    1. Baker CE, Smith I. Sevoflurane: A comparison between vital capacity and tidal breathing techniques for the induction of anaesthesia and laryngeal mask airway placement. Anaesthesia 1999;54:841–844. - PubMed

MeSH terms